23andme
'Difficult but Necessary': 23andMe Is Cutting 40% of Its Workforce
About two out of five employees are affected.
'Surprised and Disappointed': All Independent Board Members of 23andMe Resign, Leaving Only the CEO
The independent directors had two reasons for resigning.
23andMe DNA Technology Helps Family Find Kidnapped Daughter After 51 Years
Melissa Highsmith disappeared from her home as a baby in Fort Worth, Texas in 1971.
23andMe Lays Off 100 Workers Amid Shrinking Demand for DNA Tests
It's not the hot market the company predicted.
Being a Morning Person Is in Your DNA, Says 23andMe
The results of the new study point to 15 different DNA locations associated with being "a morning person."
FDA Clears 23andMe to Provide (Some) Genetic Data to Customers
The startup can now market direct-to-consumer genetic tests that include carrier status, wellness trait and ancestry reports.
Meet Color Genomics, the Startup That Wants to Make Genetic Testing Less Expensive
The Silicon Valley startup just raised $15 million in funding from PayPal co-founder Max Levchin, Yahoo's Jerry Yang and other high-profile investors.
FDA Grants 23andMe Approval to Sell Test for Rare Genetic Condition
It's a small but definite step towards 23andMe's goal of selling DNA kits again.
23andMe's Database of Genetic Information Is Going to Make It Lots of Money
The company just announced a lucrative deal with the biotech firm Genetech, and says many similar deals are in the works.
How 23andMe Caused a Divorce: A Look at Unintended Consequences
A look at what happens when customers use a business for their own purposes, regardless of the company's explicit mission.
Google Wants to Build a Model of Perfect Human Health
Big data, meet genetic data. Baseline Study, a Google X project, will collect genetic information from volunteers in order to refine the detection and prevention of diseases.
Google Is Interested in Your Health, But Deterred by Regulations
In an extensive interview with venture capitalist Vinod Khosla, Google founders Sergey Brin and Larry Page explained why regulations are hampering improvements in health care.
In Taking Aim at 23andMe, Regulators Missed the Mark
The controversy over genetic-testing company 23andMe begs the question: Is knowledge really that dangerous?
FDA Tells 23andMe to Quit Selling Genetic Testing Kits
The Food and Drug Administration said the popular genetics testing kits are being sold without 'marketing clearance or approval.'